Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

IMPORTANCE: The role of epidermal growth factor receptor (EGFR) inhibition in chemoradiation strategies in the nonoperative treatment of patients with esophageal cancer remains uncertain. OBJECTIVE: To evaluate the benefit of cetuximab added to concurrent chemoradiation therapy for patients undergoi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Suntharalingam, Mohan, Winter, Kathryn, Ilson, David, Dicker, Adam P., Kachnic, Lisa, Konski, André, Chakravarthy, A. Bapsi, Anker, Christopher J., Thakrar, Harish, Horiba, Naomi, Dubey, Ajay, Greenberger, Joel S., Raben, Adam, Giguere, Jeffrey, Roof, Kevin, Videtic, Gregory, Pollock, Jondavid, Safran, Howard, Crane, Christopher H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710193/
https://ncbi.nlm.nih.gov/pubmed/28687830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.1598
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados